1 for Tick-borne Diseases
This trial will help researchers learn more about how people's bodies respond to tick bites, which could lead to the development of vaccines against ticks in the future.
- Tick-borne Diseases
- Tick Resistance
- Lyme Disease
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
What objectives is this research endeavor striving to realize?
"This clinical trial aims to assess the safety of a particular device. Safety monitoring and toxicity tables will be used as per protocol, while its secondary objectives are exploratory in nature. Specifically, these include determining the effects of multiple tick feedings on local immune responses at bite sites; comparing changes between early and late cellular recruitment following 1st and 3rd exposures; analysing how systemic immunity develops after Ixodes scapularis bites by measuring antibody response against salivary protein antigens; and exploring skin biopsies collected at Day 1 & 4 for potential differences in their early-to-late immune reactions. Results from this study"
To what extent has this research garnered participation?
"Affirmative. Clinicaltrials.gov's records indicate that this medical research, which was initially publicized on September 14th 2021 is actively enrolling participants. 60 people need to be recruited from a single site."
Are there any available places in this research project for participants?
"Affirmative, clinicaltrials.gov displays that this medical trial is in need of participants. It was first published on September 14th 2021 and has been recently revised on the 8th of the same month. There are 60 vacancies to be filled at one site only."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- National Institutes of Health Clinical Center: < 48 hours
Average response time
- < 2 Days